About this trial
Visceral obesity is a well-established risk factor for the development of chronic non-communicable diseases (NCDs). Epicardial fat tissue (EFT) is located on the surface of the myocardium and may directly affect cardiac function and contribute to structural and functional remodeling.
According to the literature, increased EFT thickness is associated with a wide range of NCDs, disease severity, and prognosis.
The aim of this study is to investigate the associations between EFT thickness and clinical and anamnestic parameters, as well as to evaluate the prognostic value of this parameter in patients aged 50-70 years from the Russian Federation, Kazakhstan, Uzbekistan, and Kyrgyzstan.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 50-70 years undergoing transthoracic echocardiography in inpatient or outpatient settings;
Ability and willingness to provide informed consent.
Disqualifiers
Refusal to sign informed consent;
Inability to perform transthoracic echocardiography or poor image quality;
Severe psychiatric disorders.
Trial population
Patients from the Russian Federation, Kazakhstan, Uzbekistan, and Kyrgyzstan
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Composite endpoint - all-cause mortality - hospitalizations - major adverse cardiovascular events (MACE)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.